Lazishvili, 30, tested positive for clomiphene and its metabolites as the result of samples collected in-competition at UFC Fight Night on October 23, 2021, and out-of-competition on November 5, 2021. Clomiphene is a Specified Substance in the category of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.
Upon being added to the UFC Anti-Doping Program, athletes are required to declare prohibited substances they have used in the previous 12 months, prior to being in USADA’s testing program. An athlete who makes such a declaration will not be deemed to have committed a violation but, depending on the substance, will be required to refrain from competition for a period of at least six months and provide at least two negative samples to ensure that they do not compete in a UFC bout with a performance advantage.
While Lazishvili provided sufficient evidence that his use of clomiphene occurred prior to entering the program, he did not declare clomiphene on his onboarding declaration form and therefore he faces a violation for the presence of the substance in his samples. Lazishvili received a reduction to the period of ineligibility for his Full and Complete Cooperation.
Lazishvili’s 10-month period of ineligibility began on October 23, 2021, the date his first positive sample was collected. Lazishvili’s positive test also falls under the jurisdiction of the Nevada State Athletic Commission, which is resolving the case in accordance with its rules.
USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, the agency manages a drug reference hotline, Drug Reference Online, conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List and periodic athlete alerts. Many of the resources available to athletes are provided in multiple languages, including Russian, Spanish, French, Portuguese, Korean, and Japanese.
USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by text at 87232 (“USADA”), by email at playclean@USADA.org, by phone at 1-877-Play Clean (1-877-752-9253), or by mail.
